27 results on '"Malaguti, Paola"'
Search Results
2. MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)–Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors—A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study
3. T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer
4. MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)–Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors—A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study
5. Abstract OT1-16-01: Trial In Progress: An Evaluation of FACIT-Fatigue in Patients with Locally Advanced or Metastatic Breast Cancer receiving Treatment with Taxane-based Chemotherapy
6. The immersive experience of virtual reality during chemotherapy in patients with early breast and ovarian cancers: The patient’s dream study
7. AXL Receptor in Breast Cancer: Molecular Involvement and Therapeutic Limitations
8. Nanoparticle albumin-bound paclitaxel/liposomal-encapsulated doxorubicin in HER2-negative metastatic breast cancer patients
9. Fixed dose-rate gemcitabine infusion as first-line treatment for advanced-stage carcinoma of the pancreas and biliary tree
10. Pilot study of celecoxib and infusional 5-fluorouacil as second-line treatment for advanced pancreatic carcinoma
11. Activity of Eribulin Mesylate in Brain Metastasis from Breast Cancer: A Stone in a Pond?
12. The ErbB2 receptor in gastric cancer. the quick-change artist
13. First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?
14. Palbociclib: efficacious but predictive biomarkers still needed
15. Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patients
16. Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patients
17. [Pharmacogenomics and chemotherapy]
18. Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study
19. Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study
20. Phase II study on weekly bolus topotecan in advanced or recurrent cervical cancer
21. Epidermal growth factor receptor gene copy number may predict lapatinib sensitivity in HER2-positive metastatic breast cancer
22. An update on palonosetron hydrochloride for the treatment of radio/chemotherapy-induced nausea and vomiting
23. Unusual liver locations of growing teratoma syndrome in ovarian malignant germ cell tumors
24. A Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of 5-Fluorouracil Degradation Rate by Intact Peripheral Blood Mononuclear Cells
25. An update on palonosetronhydrochloride for the treatment of radio/chemotherapy-induced nausea and vomiting
26. Fixed dose-rate gemcitabine (FDR-Gem) infusion as first-line treatment for advanced pancreatic and biliary tree cancer
27. The Mammalian target of rapamycin inhibitors in breast cancer: current evidence and future directions.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.